Chest
-
Diffuse Lung Disease Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: From 2009 to 2013, we identified four Goodpasture disease as severe alveolar hemorrhage. ⋯ The following authors have nothing to disclose: Olivier Gilbert, Alain Van Meerhaeghe, Benoit Guillaume, Thibault Richard, Maxime Vancutsem, Philippe PierardNo Product/Research Disclosure Information.
-
Transplantation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: We want to share our experience with extracorporeal membrane oxigenation system (ECMO) in the management of a primary graft dysfunction after lung transplantation. ⋯ The following authors have nothing to disclose: José González García, Sebastian Peñafiel, Eugenia Libreros Niño, Diana Baquero Velandia, Victor Calvo Medina, Carlos Jordá Aragón, Gabriel Sales Badia, Juan Escrivá, Ángel García Zarza, Juan Pastor GuillemNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Lyme disease is a tick-borne illness caused by spirochete Borrelia Burgdorferi. Cardiac manifestations of Lyme disease mostly include conduction abnormalities which occur weeks to a few months after the onset of infection. ⋯ Lyme Carditis should be suspected as the cause of AV conduction block in the setting of a travel history to Lyme endemic area and Erythema Migrans rash, with or without the history of a tick bite.Reference #1: N/ADISCLOSURE: The following authors have nothing to disclose: Sameer Chadha, Geurys Rojas Marte, Bernard Topi, Gerald Hollander, Jacob ShaniNo Product/Research Disclosure Information.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The aim of our study was to evaluated the capacity of NT-proBNP to identify high risk patients with COPD exacerbations. ⋯ The following authors have nothing to disclose: Elena Garcia Castillo, Tamara Alonso Pérez, Gonzalo Segrelles Calvo, Olga Rajas Naranjo, Enrique Zamora García, Julio AncocheaNo Product/Research Disclosure Information.
-
ILD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Idiopathic Pulmonary Fibrosis (IPF) is a progressive fatal diffuse parenchymal disease. Pulmonary hypertension (PH) in IPF has been increasingly recognized as a condition with significant prognostic relevance. PH usually develops in patients with advanced IPF however there exists a subset of patients who develop PH at earlier stages. The objective of this study is to compare clinical, functional and radiological parameters in patients with IPF with and without PH at presentation. ⋯ The following authors have nothing to disclose: Margarida Redondo, Diogo Costa, Natalia Melo, Patricia Mota, Antonio MoraisNo Product/Research Disclosure Information.